Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane
Crossref DOI link: https://doi.org/10.1007/s00280-016-3179-3
Published Online: 2016-10-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nomura, Motoo
Iwasa, Satoru
Tsushima, Takahiro
Kato, Ken
Yasui, Hirofumi
Boku, Narikazu
Muto, Manabu
Muro, Kei
License valid from 2016-10-24